title: [The use of a biospecific antiproteinase hemosorbent in the combined treatment of acute destructive pancreatitis].
abstract: Results of treatment of 32 patients with acute destructive pancreatitis are presented. Hemosorption on biospecific antiproteinase hemosorbent "OVOSORB" possessing the property of extraction of the excess of serine proteinases from blood plasma was used. High efficiency of the sorbent for treatment of destructive pancreatitis was shown. This effect was obtained at the expense of correction of hyperproteasemia, normalization of protein metabolism as well as prevention of the production and accumulation of middle molecule peptides possessing various pathological properties in the fluid media of the organism.
authors.forename: V V
authors.initials: VV
authors.lastname: Kirkovskiĭ
authors.forename: O F
authors.initials: OF
authors.lastname: Antiperovich
authors.forename: V M
authors.initials: VM
authors.lastname: Moin
authors.forename: L I
authors.initials: LI
authors.lastname: Mazur
authors.forename: G A
authors.initials: GA
authors.lastname: Lobacheva
authors.forename: O G
authors.initials: OG
authors.lastname: Berezkina
authors.forename: V S
authors.initials: VS
authors.lastname: Kushnirenko
mesh_terms: D000208:Acute Disease; D003131:Combined Modality Therapy; D005069:Evaluation Studies as Topic; D006464:Hemoperfusion / Q000379:methods*; D006801:Humans; D010059:Ovomucin / Q000627:therapeutic use*; D010195:Pancreatitis / Q000097:blood / Q000628:therapy*; D011182:Postoperative Care / Q000379:methods; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use*
chemical_list: D015842:Serine Proteinase Inhibitors; C073841:Ovosorb; D010059:Ovomucin